Stockscreener 앱 받기
7.13
0.56%
-0.04
시간 외 거래:
7.22
0.09
+1.26%
전일 마감가:
$7.17
열려 있는:
$7.2
하루 거래량:
66,483
Relative Volume:
0.95
시가총액:
$13.43M
수익:
-
순이익/손실:
$-26.56M
주가수익비율:
-0.1612
EPS:
-44.2199
순현금흐름:
$-28.59M
1주 성능:
+0.28%
1개월 성능:
-37.40%
6개월 성능:
+146.71%
1년 성능:
+6.34%
1일 변동 폭
$6.96
$7.3249
1주일 범위
$6.88
$8.16
52주 변동 폭
$0.61
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
명칭
Briacell Therapeutics Corp
전화
(604) 921-1810
주소
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
BCTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
7.13 | 13.51M | 0 | -26.56M | -28.59M | -44.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-02-14 | 개시 | H.C. Wainwright | Buy |
Briacell Therapeutics Corp 주식(BCTX)의 최신 뉴스
How $594B in Precision Tech is Cracking the Metastatic Cancer Code - The Globe and Mail
(BCT) Trading Advice (BCT:CA) - Stock Traders Daily
(BCT) Investment Analysis (BCT:CA) - Stock Traders Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
BriaCell Subsidiary BriaPro Files Interim Financial Results - The Globe and Mail
(BCT) Strategic Investment Report (BCT:CA) - Stock Traders Daily
BriaCell subsidiary BriaPro files interim financial results - MSN
BriaCell Therapeutics Corp Subsidiary Files Financial Statements - TradingView — Track All Markets
BriaCell Therapeutics (BCTX) shares BriaPro Q3 2025 interim results disclosure - Stock Titan
Why BriaCell Therapeutics Corp. Equity Warrant stock is favored by pension funds - bollywoodhelpline.com
(BCT) Proactive Strategies (BCT:CA) - Stock Traders Daily
(BCT) Trading Signals (BCT:CA) - Stock Traders Daily
12 Health Care Stocks Moving In Tuesday's Intraday Session - Sahm
Form FWP BriaCell Therapeutics Filed by: BriaCell Therapeutics Corp. - StreetInsider
Profit Review: Why BriaCell Therapeutics Corp. stock remains undervaluedJuly 2025 Sector Moves & Expert-Curated Trade Recommendations - Улправда
Why hedge funds are buying BriaCell Therapeutics Corp. Equity Warrant stockMarket Activity Report & Risk Controlled Daily Plans - Улправда
Market Recap: How BriaCell Therapeutics Corp. Equity Warrant stock reacts to Fed rate cutsWeekly Stock Summary & Safe Entry Point Alerts - Улправда
Is BriaCell Therapeutics Corp. Equity Warrant stock oversold or undervaluedChart Signals & Fast Moving Trade Plans - Улправда
How BriaCell Therapeutics Corp. Equity Warrant stock reacts to Fed rate cutsCPI Data & Verified Momentum Stock Alerts - Улправда
Is BriaCell Therapeutics Corp. stock a buy for dividend growth2025 Sector Review & Reliable Breakout Forecasts - Улправда
Is BriaCell Therapeutics Corp. Equity Warrant stock recession proof2025 Year in Review & Technical Pattern Based Signals - Улправда
Will BriaCell Therapeutics Corp. stock gain from strong economyBuy Signal & Daily Stock Trend Reports - DonanımHaber
Is BriaCell Therapeutics Corp. stock a safe haven assetMarket Sentiment Summary & Technical Pattern Based Signals - DonanımHaber
Why BriaCell Therapeutics Corp. stock could benefit from AI revolutionJuly 2025 Opening Moves & Smart Investment Allocation Tips - DonanımHaber
BriaCell’s phase 3 breast cancer trial named a 2026 ‘clinical trial to watch’ by Nature Medicine - MSN
Why BriaCell Therapeutics Corp. stock remains undervalued2025 Growth vs Value & High Win Rate Trade Tips - Улправда
BriaCell’s Phase 3 Breast Cancer Trial Named a 2026 ‘Clinical Trial to Watch’ by Nature Medicine - TipRanks
"Eleven clinical trials that will shape medicine in 2026"BriaCell Phase 3 Trial Featured in Nature Medicine - Investing News Network
Briacell phase 3 trial featured in Nature Medicine - marketscreener.com
'Eleven clinical trials that will shape medicine in 2026”BriaCell Phase 3 Trial Featured in Nature Medicine - The Manila Times
Briacell Phase 3 Trial Featured In Nature Medicine - TradingView — Track All Markets
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine - GlobeNewswire
BriaCell Therapeutics : Fact Sheet (20251216 Fact Sheet) - marketscreener.com
BriaCell Therapeutics : Investor Presentation (20251216 Website Presentation) - marketscreener.com
How to Take Advantage of moves in (BCT) (BCT:CA) - Stock Traders Daily
Why Institutions Believe Bondada Engineering Limited Is Undervalued TodayMarket Liquidity Analysis & Build Wealth With Zero-Cost Tools - earlytimes.in
Rally Mode: What insider trading reveals about BriaCell Therapeutics Corp stockIPO Watch & Comprehensive Market Scan Insights - moha.gov.vn
(BCT) Trading Performance and Risk Management (BCT:CA) - news.stocktradersdaily.com
Top 3 Earnings Acceleration Buys for November - MSN
BriaCellModel Bria-IMT and Bria-OTSDestroy Cancer Cells - Environmental XPRT
BriaCell Therapeutics Corp. Reports Earnings Results for the First Quarter Ended October 31, 2025 - marketscreener.com
BriaCell (NASDAQ: BCTX) boosts R&D as going concern risk emerges - Stock Titan
BriaCell’s Bria-IMT shows promising results in metastatic breast cancer trials - MSN
BriaCell Therapeutics Corp Warrant 2021-26.02.26 on BriaCell Therapeutics - TradingView — Track All Markets
Net income of BriaCell Therapeutics Corp Warrant 2021-26.02.26 on BriaCell Therapeutics – NASDAQ:BCTXW - TradingView — Track All Markets
BriaCell reports positive data for breast cancer immunotherapy By Investing.com - Investing.com Nigeria
BriaCell (BCTX) Highlights Promising Data at 2025 SABCS Symposiu - GuruFocus
BriaCell’s Bria-IMT Shows Promising Results in Metastatic Breast Cancer Trials - TipRanks
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025 - Investing News Network
BriaCell reports positive data for breast cancer immunotherapy - Investing.com
Briacell Therapeutics Corp (BCTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):